Neupopeg has been studied in two main studies involving 467 patients with breast cancer who were being treated with cytotoxic chemotherapy.
Neupopegi uuriti kahes põhiuuringus, kus osales 467 rinnavähiga patsienti, kes said tsütotokslilist keemiaravi.